NewsSource: EClinCloud

EClinCloud Product Overview | IRC · Independent Central Imaging Assessment Solution

1 min readEClinCloud Editorial Team
EClinCloud Product Overview | IRC · Independent Central Imaging Assessment Solution news cover image

Source: EClinCloud. Author: EClinCloud.



The EClinCloud IRC (Independent Review Committee) system uses advanced AI technology and platform capabilities to integrate image upload and image reading technologies, providing single-center and multicenter clinical trials with a standardized integrated independent review management platform that meets GxP requirements. Combining an IRC service team across multiple therapeutic areas (including oncology, central nervous system, and ophthalmology) with extensive expert reader resources, EClinCloud provides reliable endpoint solutions for clinical trials.


computer-ai.png

AI-Driven One-Stop Product + Service Solution


🔍 What Can EClinCloud Provide?

◉ IRC System

◉ System Configuration Services

◉ Independent Reader Management

◉ Independent Medical Imaging Review

◉ Independent Review Project Management



💡 Why Choose EClinCloud IRC?


❖ Experienced core team covering multiple indication areas

❖ Proprietary review system integrating image upload and reading platforms

❖ End-to-end medical team follow-up to ensure review timeliness and project quality

❖ Extensive senior specialist resources across multiple therapeutic areas for more specialized review services

❖ Review system and independent review service solutions across multiple therapeutic areas, including oncology and non-oncology (ophthalmology, central nervous system, dermatology, and pulmonology)






About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated clinical intelligence cloud platform and endpoint assessment technologies to provide global pharmaceutical companies and research institutions with technical products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services. It establishes efficient and accurate digital solutions and leverages AI predictive models and an intelligent data platform to dynamically evaluate and help improve the success rate of drug clinical trials, helping shorten drug and medical device R&D cycles for the benefit of patients.  







Article illustration





Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.